InnoCore develops and manufactures injectable drug delivery products that enable sustained release of a wide range of compounds, including proteins, peptides and small molecules. Using our SynBiosys® and InGell® biodegradable polymer platforms we offer optimal control over the release kinetics and bioactivity of biological therapeutics.
| Micro spheres | Implants | Coating | Gels | In situ forming depots | |
|---|---|---|---|---|---|
| Small molecules | Our solution: SynBiosys® | Our solution: InGell® | Our solution: SynBiosys® | ||
| Peptides | |||||
| Proteins | In development | In development | |||
| Oligonucleotides | |||||
| Other | Contact us to discuss the possibilities | ||||
InnoCore takes products from early pre-clinical development into the clinic, as an extension of your R&D lab, by providing formulation development, process development, optimization and upscaling. Our solutions are applied to a variety of therapeutic areas such as Cardiology, Oncology, Ophthalmology, Osteoarthritis, Urology, Pain, Diabetes, CNS, Infectious diseases and Immunology.
